As you ascend the hill of the famous Bothell’s Park, you won’t help but notice a group of dull-colored buildings. These buildings house one of the leading enterprises in genetics. Seattle Genetics is a company that focuses on developing antibodies to fight diseases such as cancer. The company has been forefront in developing antibodies that effectively target cancer cells in the human body and eventually kill the cancer cells.
Since the founding of Seattle genetics, this company has extensively researched on methods that can efficiently help reduce the cancer scourge in the world. Developing antibodies to cure cancer is a method that is now being used by this company. Currently, Seattle genetics is led by the co-founder and the CEO of the company, Clay Siegall. Through his leadership, Seattle genetics has expanded to be among the best biotech enterprises in the industry.
The company has enjoyed massive success in revenue due to a variety of reasons. First and foremost, Seattle genetics employs experts in Oncology. These experts are responsible for the company developing highly efficient drugs like the ADC. ADC is a type of antibody conjugate that attaches to antigens in the body and thereby killing the cancerous cells. Besides, Seattle genetics is developing a batch of drugs that have proved efficient in combatting diseases such as leukemia.
Secondly, the company has experienced sales and marketing team, the team works tirelessly to push the drugs that have been developed in the market. Currently, Seattle genetics has over 410 million dollars in sales as of December 2016. This does not include the sales projections of new drugs that have been recently developed.
Clay Siegall is the current CEO and benefactor of Seattle genetics. He co-founded this firm in 1998 alongside his business patter and longtime friend. Besides, he is also on the board of Seattle genetics. Before being the chief executive officer at Seattle Genetics, he worked at the Bristol-Myers Squibb Company. This company was a pharmaceutical firm that dealt in the research of new and improved drugs.
Dr. Clay Siegall learned at the George Washington University and the University of Maryland. He graduated with a Ph.D. in genetics and a degree in zoology from these universities respectively. Dr. Clay Siegall attributes his leadership skills to the time he spent as a student of genetics. Here, he acquired vital skills such as patience, determination, and commitment. These attributes have been useful in catapulting him to prominence.